SFS
BPMC

Sowell Financial Services’s Blueprint Medicines BPMC Stock Holding History

Sowell Financial Services’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-165
Closed -$15K – 815
2021
Q1 		$15K Sell
165
-25
-13% -$2.5K ﹤0.01% 2147
2020
Q4 		$21K Hold
190
– – ﹤0.01% 1714
2020
Q3 		$18K Hold
190
– – ﹤0.01% 1594
2020
Q2 		$15K Hold
190
– – ﹤0.01% 1543
2020
Q1 		$11K Hold
190
– – ﹤0.01% 1568
2019
Q4 		$15K Hold
190
– – ﹤0.01% 1533
2019
Q3 		$14K Buy
+190
New +$16.4K ﹤0.01% 1406

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Sowell Financial Services's BPMC Position: Q2 2021 in Review

Sowell Financial Services sold out of Blueprint Medicines (BPMC) in Q2 2021, closing a stake of 165 shares — an estimated $15K sold.

Sowell Financial Services first reported a position in BPMC in Q3 2019 and held it in 7 quarters. The position peaked at $21K in Q4 2020. 281 funds tracked by Wall St. Rank hold BPMC as of Q2 2021.

  • Sowell Financial Services reported no remaining Blueprint Medicines position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 165 Blueprint Medicines shares in Q2 2021, an estimated $15K.
  • Sowell Financial Services first reported a position in Blueprint Medicines in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Blueprint Medicines position peaked at $21K in Q4 2020.
  • 281 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.